Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lazard Ltd (LAZ), Evercore Partners Inc. (EVR): Betting on Boutique Investment Banks

Big Investment banking firms such as Morgan Stanley (NYSE:MS), Barclays or even the almighty Goldman Sachs Group, Inc. (NYSE:GS) have shown that they are houses where conflicts of interests abound (think of Goldman’s scandalous CDO pre-crisis structuring).

The crisis that wiped off Lehman Brothers also generated a historic opportunity for smaller investments banks. From then on, smaller firms could grab a bigger chunk of the total banking fee pie (coming from restructurings, M&A advice and all other investment banking related activities).

Here I take the case of three banks and I will try to decide which one has the best possibility of becoming the next big success story within the industry. The boutique banks I would like to review are Lazard Ltd (NYSE:LAZ)Evercore Partners Inc. (NYSE:EVR) and Greenhill & Co., Inc. (NYSE:GHL).

While Lazard Ltd (NYSE:LAZ) is already a bigger and more mature company, Evercore Partners Inc. (NYSE:EVR) and Greenhill are still in their adolescent phase. They are both constantly reshaping their business models to see what best fits what they both want to achieve. Despite their relative success, not so long ago both companies missed Wall Street estimates in their first-quarter results. When Greenhill & Co., Inc. (NYSE:GHL) presented weaker than anticipated M&A revenues its stock fell as much as 10%. Evercore’s earnings miss was less severe, and its shares fell by 1% but, still, I felt disappointed with the overall result of the bank in the M&A ranking table.

Even if Greenhill & Co., Inc. (NYSE:GHL) and Evercore Partners Inc. (NYSE:EVR) are roughly the same size (both companies have a market capitalization in the range between $1 and $1.5 billion), the two banks have a very different business strategy. While Greenhill only gives deal advice, Evercore counts with an asset management business (generating 10% of total revenue) and provides equity underwriting. Since Evercore’s business is more capital intensive, its operating margins are lower. Evercore’s 21% operating margin is well below Greenhill’s 25%.

The two boutique banking companies have opposing views on what “investment banking” should be about. While Greenhill believes that activities related to investing could create conflicts with its clients (again, remember Goldman Sachs’s CDO case), Evercore thinks that lending and trading to clients helps the firm to give better advice through deeper market knowledge.

Lazard Ltd (NYSE:LAZ) is another story. The company is almost four times bigger than the competitors I just mentioned above (its market capitalization stands at $3.9 billion). Lazard Ltd (NYSE:LAZ)’s business model resembles closer the model chosen by Evercore since its two business segments are asset management and advisory. The company has yet to present first quarter results but expectations are set low for the same reasons they were low for Greenhill and Evercore Partners Inc. (NYSE:EVR): the low M&A activity during the first quarter of the year.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.